Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole sodium PK/PD in healthy Japanese males
NCT01202071Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by Eisai Co., Ltd.. Started Sep 2010; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01202071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202071.